Prognostic impact of CXCR4 and other prognostic variables on overall survival and relapse-free survival
Variable . | Univariate . | Multivariate . | ||||
---|---|---|---|---|---|---|
HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
Overall survival* | ||||||
CXCR4 MFIR | 2.699 | 1.327-5.489 | .006 | 2.007 | 1.044-3.858 | .037 |
LDH level | 2.436 | 1.152-5.151 | .02 | — | — | — |
Unfavorable cytogenetics | 2.182 | 1.146-4.154 | .018 | 2.478 | 1.129-5.441 | .024 |
Relapse-free survival† | ||||||
CXCR4 MFIR | 3.853 | 1.298-11.442 | .015 | 3.853 | 1.298-11.442 | .015 |
WBC count | 0.315 | 0.124-0.802 | .015 | — | — | — |
Unfavorable cytogenetics | 2.283 | 0.986-5.286 | .054 | — | — | — |
Variable . | Univariate . | Multivariate . | ||||
---|---|---|---|---|---|---|
HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
Overall survival* | ||||||
CXCR4 MFIR | 2.699 | 1.327-5.489 | .006 | 2.007 | 1.044-3.858 | .037 |
LDH level | 2.436 | 1.152-5.151 | .02 | — | — | — |
Unfavorable cytogenetics | 2.182 | 1.146-4.154 | .018 | 2.478 | 1.129-5.441 | .024 |
Relapse-free survival† | ||||||
CXCR4 MFIR | 3.853 | 1.298-11.442 | .015 | 3.853 | 1.298-11.442 | .015 |
WBC count | 0.315 | 0.124-0.802 | .015 | — | — | — |
Unfavorable cytogenetics | 2.283 | 0.986-5.286 | .054 | — | — | — |